JAMA Network
About The Study: The results of this study including 121,000 Singaporean children ages 1 through 4 suggest that completion of a primary mRNA vaccine series provided protection against SARS-CoV-2 infection. Although incidence of hospitalization and severe illness is low in this age group, there is potential benefit of vaccination in preventing infection and potential sequelae.
Authors: Liang En Wee, M.R.C.P., M.P.H., of the National Centre for Infectious Diseases in Singapore, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2023.4505)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
